These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression. Yang Q; Titus MA; Fung KM; Lin HK J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593 [TBL] [Abstract][Full Text] [Related]
6. Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Yan TZ; Jin FS; Xie LP; Li LC Urol Int; 2008; 81(2):228-33. PubMed ID: 18758226 [TBL] [Abstract][Full Text] [Related]
7. Co-targeting androgen receptor and DNA for imaging and molecular radiotherapy of prostate cancer: in vitro studies. Han G; Kortylewicz ZP; Enke T; Baranowska-Kortylewicz J Prostate; 2014 Dec; 74(16):1634-46. PubMed ID: 25214432 [TBL] [Abstract][Full Text] [Related]
8. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells. Yemelyanov A; Czwornog J; Gera L; Joshi S; Chatterton RT; Budunova I Cancer Res; 2008 Jun; 68(12):4763-73. PubMed ID: 18559523 [TBL] [Abstract][Full Text] [Related]
9. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of isoflavones on prostate cancer cells and PTEN gene. Cao F; Jin TY; Zhou YF Biomed Environ Sci; 2006 Feb; 19(1):35-41. PubMed ID: 16673816 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone. Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712 [TBL] [Abstract][Full Text] [Related]
12. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Waltering KK; Helenius MA; Sahu B; Manni V; Linja MJ; Jänne OA; Visakorpi T Cancer Res; 2009 Oct; 69(20):8141-9. PubMed ID: 19808968 [TBL] [Abstract][Full Text] [Related]
13. The immunophilin ligands cyclosporin A and FK506 suppress prostate cancer cell growth by androgen receptor-dependent and -independent mechanisms. Periyasamy S; Warrier M; Tillekeratne MP; Shou W; Sanchez ER Endocrinology; 2007 Oct; 148(10):4716-26. PubMed ID: 17615153 [TBL] [Abstract][Full Text] [Related]
14. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA]. Zhang BY; Li YF; Lai Y; Li YS; Chen ZJ Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(5):950-6. PubMed ID: 26087562 [TBL] [Abstract][Full Text] [Related]
15. Context dependent regulatory patterns of the androgen receptor and androgen receptor target genes. Olsen JR; Azeem W; Hellem MR; Marvyin K; Hua Y; Qu Y; Li L; Lin B; Ke X; Øyan AM; Kalland K BMC Cancer; 2016 Jul; 16():377. PubMed ID: 27378372 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 17A1 inhibitor abiraterone attenuates cellular growth of prostate cancer cells independently from androgen receptor signaling by modulation of oncogenic and apoptotic pathways. Grossebrummel H; Peter T; Mandelkow R; Weiss M; Muzzio D; Zimmermann U; Walther R; Jensen F; Knabbe C; Zygmunt M; Burchardt M; Stope MB Int J Oncol; 2016 Feb; 48(2):793-800. PubMed ID: 26648519 [TBL] [Abstract][Full Text] [Related]
17. Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. Dong Z; Liu Y; Lu S; Wang A; Lee K; Wang LH; Revelo M; Lu S Mol Endocrinol; 2006 Oct; 20(10):2315-25. PubMed ID: 16762975 [TBL] [Abstract][Full Text] [Related]
18. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model. McGregor N; Patel L; Craig M; Weidner S; Wang S; Pienta KJ J Cell Biochem; 2010 Aug; 110(5):1187-94. PubMed ID: 20589722 [TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays. Kim HJ; Park YI; Dong MS Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434 [TBL] [Abstract][Full Text] [Related]
20. New steroidal 17β-carboxy derivatives present anti-5α-reductase activity and anti-proliferative effects in a human androgen-responsive prostate cancer cell line. Amaral C; Varela C; Correia-da-Silva G; Tavares da Silva E; Carvalho RA; Costa SC; Cunha SC; Fernandes JO; Teixeira N; Roleira FM Biochimie; 2013 Nov; 95(11):2097-106. PubMed ID: 23933094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]